Assessment of effect of autologus serum therapy on severe chronic urticaria and comparison with placebo injections
Phase 2
- Conditions
- severe chronic urticaria.Idiopathic urticaria
- Registration Number
- IRCT2014061818137N1
- Lead Sponsor
- niversity of Medical Sciences Shiraz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
patients entered the study had severe urticaria for at least 6 weeks in most of the days; not responding to antihistamines? patients who had no other systemic disease; those with negative food allergy skin test; patients without urticaria vasculitis.
Exclusion criteria: patients with systemic disease; those who had positive allergy skin test with food; those who had a good response to antihistamines.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Questionnaire. Timepoint: Before onset of treatment and end of weekly treatment and end of monthly treatment. Method of measurement: physical examination and history.
- Secondary Outcome Measures
Name Time Method